Squarepoint’s InVivo Therapeutics Holdings NVIV Stock Holding History
Bought
Maintained
Sold
Other funds holding NVIV
BBA
Squarepoint's NVIV Position: Q1 2017 in Review
Squarepoint sold out of InVivo Therapeutics Holdings (NVIV) in Q1 2017, closing a stake of 1 share — an estimated $46K sold.
Squarepoint first reported a position in NVIV in Q4 2016 and held it in 1 quarter. The position peaked at $46K in Q4 2016. 42 funds tracked by Wall St. Rank hold NVIV as of Q1 2017.
- Squarepoint reported no remaining InVivo Therapeutics Holdings position as of Q1 2017 after selling out during the quarter.
- Squarepoint sold 1 InVivo Therapeutics Holdings share in Q1 2017, an estimated $46K.
- Squarepoint first reported a position in InVivo Therapeutics Holdings in Q4 2016 and held it in 1 quarter.
- Squarepoint's InVivo Therapeutics Holdings position peaked at $46K in Q4 2016.
- 42 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings as of Q1 2017.
Based on Squarepoint's 13F filing for Q1 2017, filed 15 May 2017.